intrasphincteric injection of 150 x 10 6 AMDC-USR or vehicle placebo and 1:1 to receive 1 or 2 treatments. Second treatments were administered 6 months after first treatments. At baseline and follow-up, SUI was monitored by 3-day diaries of stress incontinence episode frequency (IEF), 24-hour pad tests, in-office pad tests, and quality of life (QOL) questionnaires. The primary composite efficacy endpoint was the percentage of patients with 50% IEF reduction or 50% reduction in either pad test 12 months post-treatment. Patients were unblinded after completing 12-month visits, and patients who received placebo could opt to receive an open-label AMDC-USR treatment. Patients were followed for 2 years after initial treatment.
INTRODUCTION AND OBJECTIVES: Multiple sclerosis (MS)
is characterized by demyelinated white matter plaque throughout the central nervous system. Patients with MS frequently experience a range of bothersome urinary symptoms. The cingulate cortex, insula cortex, and prefrontal cortex are three cortical brain regions that regulate micturition, and plaque involvement in these regions may be associated with urinary symptom severity. The aim of this study is to investigate the relationship between cerebral plaque volume, location, and urinary symptoms in women with MS.
METHODS: We conducted a prospective case control study of women with MS undergoing routine yearly brain MRI. Women were administered the AUA Symptom Score (AUASS) and divided into two groups: women with severe urinary symptoms (AUASS 20) and women with mild symptoms (AUASS 7). MS plaque volume and location in the brain were determined using a validated automated white matter lesion segmentation algorithm. Mann Whitney U and Spearman's rank tests were used to investigate the relationship between plaque volume, location, and AUASS subscale scores.
RESULTS: The study included 36 women with a median age of 50.1 years (IQR 27.1) and BMI 26.6 kg/m2 (IQR 5.8) with no significant differences between groups, p>0.05. The median total plaque volume was 2523.5mm 3 (IQR 11705.5) and did not differ between the groups, p¼0.52. Women with severe urinary symptoms had larger median plaque volume in the left frontal lobe (LFL) (623.5mm 3 IQR 2652 vs. 184mm 3 IQR 908; p¼0.04) and right limbic lobe (RLL) (1.5mm 3 IQR 10 vs. 0 IQR 0; p¼0.02) compared to women with mild urinary symptoms. Within the RLL, women with severe symptoms had larger median plaque volume in the cingulate gyrus (median 1 IQR 4 vs. median 0 IQR 0; p¼0.02). There was moderate correlation between LFL lesion volume and the AUA voiding symptom subscore (coefficient 0.4, p¼0.03) as well as RLL lesion volume and the AUA voiding symptom subscore (coefficient 0.5, p¼0.002). However, these regions did not correlate with the storage subscore. There were no significant relationships between symptoms severity and plaque volume in the insula, cerebellum, corpus callosum, occipital or parietal lobes (p>0.05).
CONCLUSIONS: Urinary symptom severity in women with MS is associated with plaque in the cingulate gyrus and LFL, and not total cerebral plaque volume. The voiding symptom subscore of AUASS correlated with the volume of plaque in these locations. Further research to assess spinal cord plaque characteristics is underway.
Source of Funding:
Funding provided by the National Institute of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant number P20 DK097819-01.
PNFBA-05 SPECIFIC CHANGES IN BRAIN ACTIVITY IN WOMEN WITH OVERACTIVE BLADDER AFTER SUCCESSFUL SACRAL NEUROMODULATION WITH INTERSTIMâ: AN FMRI STUDY
Steven Weissbart*, Stony Brook, NY; Rupal Bhavsar, John Detre, Hengyi Rao, Alan Wein, Lily Arya, Ariana Smith, Philadelphia, PA INTRODUCTION AND OBJECTIVES: Sacral neuromodulation (SNS) with InterStimâ is efficacious for the treatment of overactive bladder (OAB); however, its mechanism of action is unclear, and there are no objective markers of response. Prior functional neuroimaging studies have suggested that women with OAB have increased brain activity in the cingulate cortex, insula, and frontal cortex, in response to bladder filling. The aim of this study was to investigate the effect of SNS on brain activity in women with OAB.
METHODS: We conducted a prospective mechanistic study of women with OAB (measured on validated questionnaire) undergoing InterStimâ. Prior to stage 1 InterStimâ, women underwent BOLD fMRI during bladder filling. During filling, women were asked to signal the experience of urgency. Women who completed stage 2 InterStimâ underwent a 2nd BOLD fMRI during bladder filling 6 weeks after e610 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 
